New England Journal of Medicine · 2004 · 48 citations · 1 references
Life SciencesCell BiologyDevelopmental BiologyEmbryologyRegenerative MedicineStem Cell BiologyCell Line DevelopmentCell SourcesCell-based TherapiesEmbryonic Stem CellsPluripotent Stem CellsStem Cell EthicsAccess To Stem Cell TherapiesEmbryonic Stem Cell Research EthicsHuman Embryonic Stem Cell PolicyHuman Embryonic Stem CellsStem Cell-derived Cell Lines
Three years have passed since August 9, 2001, when President George W. Bush drew a line in the sand: he announced that research on human embryonic stem cells created before that date would be supported by federal dollars; research on lines created later would not. The President's policy has severely curtailed opportunities for U.S. scientists to study the cell lines that have since been established, many of which have unique attributes or represent invaluable models of human disease.Some 128 new human embryonic stem-cell lines have been produced worldwide since the President's announcement.1 Douglas Melton et al. of Harvard University . . .
1